|
FAM103A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.031190E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.792200E-01 |
| Normal-vs-Stage2 |
4.963600E-01 |
| Normal-vs-Stage3 |
7.299500E-03 |
| Normal-vs-Stage4 |
1.012790E-01 |
| Stage1-vs-Stage2 |
8.996800E-01 |
| Stage1-vs-Stage3 |
7.615500E-03 |
| Stage1-vs-Stage4 |
2.049600E-01 |
| Stage2-vs-Stage3 |
1.724030E-01 |
| Stage2-vs-Stage4 |
4.924800E-01 |
| Stage3-vs-Stage4 |
3.669400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.237900E-02 |
| Normal-vs-AfricanAmerican |
5.549200E-01 |
| Normal-vs-Asian |
6.124600E-01 |
| Caucasian-vs-AfricanAmerican |
4.381200E-01 |
| Caucasian-vs-Asian |
9.256600E-01 |
| AfricanAmerican-vs-Asian |
8.504200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.380630E-01 |
| Normal-vs-Female |
1.005180E-01 |
| Male-vs-Female |
7.647000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.760800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.192000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.277600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.612600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.070400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.407400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.166800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.760000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.628600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.513800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.028400E-01 |
| Normal-vs-Grade 2 |
6.116600E-01 |
| Normal-vs-Grade 3 |
7.858300E-03 |
| Normal-vs-Grade 4 |
7.679500E-02 |
| Grade 1-vs-Grade 2 |
9.899000E-01 |
| Grade 1-vs-Grade 3 |
2.725600E-01 |
| Grade 1-vs-Grade 4 |
4.351800E-01 |
| Grade 2-vs-Grade 3 |
6.456600E-03 |
| Grade 2-vs-Grade 4 |
1.162160E-01 |
| Grade 3-vs-Grade 4 |
8.094000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.662430E-01 |
| Normal-vs-ccB subtype |
2.236000E-01 |
| ccA subtype-vs-ccB subtype |
9.917400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.005610E-01 |
| Normal-vs-N1 |
6.125800E-01 |
| N0-vs-N1 |
7.168400E-01 |
|
|
